Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting
SAN DIEGO, Sept. 28, 2023 -- Turnstone Biologics Corp. , a clinical-stage biotechnology company developing new medicines to treat and cure solid tumors by pioneering a differentiated approach to...
Source: marketscreener.com